B. Braun Medical Statement on Hurricane Milton Impact

Our Daytona Beach IV solutions manufacturing site and distribution center were not seriously impacted by Hurricane Milton and have resumed normal operations. We understand from discussions with employees that there have been no reported injuries, but many are still without power. We are especially thankful to the employees who remained at the site to provide updates throughout the storm.

To safeguard the supply of finished products, we worked closely with the federal government, specifically the Administration for Strategic Preparedness and Response (ASPR), to leverage their resources which allowed us to move IV solutions inventory from our Daytona Beach distribution center to a secure, temperature-controlled facility north of Florida. The product will now be returned to our distribution site.

We are in daily contact with officials from ASPR, the Drug Shortage staff at CDER (Center for Drug Evaluation and Research) and the Department of Health and Human Services to address this issue and help alleviate any impact on patient care.

The Daytona Beach facility is a key part of our plan to help address the shutdown of Baxter’s IV solutions manufacturing facility in North Carolina. In partnership with ASPR, we are taking immediate steps to increase production of critical IV fluids at our plant in Irvine, CA and will resume this plan at Daytona Beach on October 11. B. Braun supports the recommendations of the American Hospital Association, ASHP and other organizations in encouraging healthcare providers across the country to conserve their use of IV products. We are committed to doing everything we can to help ensure that patients have access to the IV therapies they need.